This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Deniz Kumbasar, S. Articles by Deger, N. Search for Related Content PubMed PubMed Citation Articles by Deniz Kumbasar, S. Articles by Deger, N. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Heart Attack Social Bookmarking                         What's this?

Concomitant Use of Intraaortic Balloon Counterpulsation and Streptokinase in Acute Anterior Myocardial Infarction

Department of Cardiology, Ankara University Medical School, Ankara, Turkey.

Ender Semiz, MD

Department of Cardiology, Akdeniz University Medical School, Antalya, Turkey.

Oktay Sancaktar, MD

Department of Cardiology, Akdeniz University Medical School, Antalya, Turkey.

Selim Yalçinkaya, MD

Department of Cardiology, Akdeniz University Medical School, Antalya, Turkey.

Cengiz Ermi, MD

Department of Cardiology, Akdeniz University Medical School, Antalya, Turkey.

Necmi Deger, MD

Department of Cardiology, Akdeniz University Medical School, Antalya, Turkey.

Using a prospective, nonrandomized design, the authors sought to determine whether concomitant use of intraaortic balloon counterpulsation (IABP) and streptokinase in acute anterior myocardial infarction (MI) would improve the in-hospital mortality rate and angiographic findings. The study included 45 patients with an acute anterior MI. All patients received intravenous streptokinase. Among these, 25 patients had concomitant IABP while the remaining 20 patients had streptokinase alone. All patients underwent cardiac catheterization. Patients treated with concomitant IABP had a significantly higher frequency of thrombolysis in myocardial infarction (TIMI) grade 3 flow (n: 11; 44% vs n: 1; 5%, p<0.05), and there was a trend toward a lower in-hospital mortality rate in the IABP group (n: 0; 0% vs n: 3; 15%, p=0.08). The angiographic presence of thrombus image and grade 2 coronary collateral circulation to the infarct-related coronary artery for the IABP and non-IABP groups did not differ significantly. The preliminary results of this study suggest that concomitant use of IABP and streptokinase in acute anterior MI increases the incidence of TIMI grade 3 flow and may have decreased the in-hospital mortality rate without unacceptable rates of vascular or hemorrhagic complications.

Angiology, Vol. 50, No. 6, 465-471 (1999)
DOI: 10.1177/000331979905000604


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?